日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome.

MPS-Authors
There are no MPG-Authors in the publication available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

2253010.pdf
(出版社版), 3MB

付随資料 (公開)

2253010_Suppl_1.pdf
(付録資料), 236KB

2253010_Suppl_3.zip
(付録資料), 9MB

2253010_Suppl_4.zip
(付録資料), 6MB

2253010_Suppl_5.zip
(付録資料), 4MB

2253010_Suppl_2.zip
(付録資料), 31MB

引用

Dudek, J., Cheng, I. F., Chowdhury, A., Wozny, K., Balleininger, M., Reinhold, R., Grunau, S., Callegari, S., Toischer, K., Wanders, R. J. A., Hasenfuss, G., Brugger, B., Guan, K. M., & Rehling, P. (2015). Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome. EMBO Molecular Medicine, 8(2), 139-154. doi:10.15252/emmm.201505644.


引用: https://hdl.handle.net/11858/00-001M-0000-0029-C6F7-8
要旨
Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre-onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac-specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell-derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome.